# Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy

> **NCT00593242** · PHASE1 · COMPLETED · sponsor: **Michael Cotten** · enrollment: 52 (actual)

## Conditions studied

- Neonatal Hypoxic Ischemic Encephalopathy

## Interventions

- **BIOLOGICAL:** infusion of autologous cord blood
- **OTHER:** Neurodevelopmental outcomes

## Key facts

- **NCT ID:** NCT00593242
- **Lead sponsor:** Michael Cotten
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593242, "Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00593242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*